Hydrochloric Acid → HCID 59828832、化合物
反応式
[CH3:1][C:2]1([C:7]2[CH:32]=[CH:31][C:10]([CH2:11][NH:12][C:13]3[C:23]4[CH2:22][CH2:21][N:20]([C:24](=[O:29])[C:25]([F:28])([F:27])[F:26])[CH2:19][CH2:18][C:17]=4[CH:16]=[CH:15][C:14]=3[Cl:30])=[CH:9][CH:8]=2)OCC[O:3]1.Cl>CO>[C:2]([C:7]1[CH:8]=[CH:9][C:10]([CH2:11][NH:12][C:13]2[C:23]3[CH2:22][CH2:21][N:20]([C:24](=[O:29])[C:25]([F:27])([F:28])[F:26])[CH2:19][CH2:18][C:17]=3[CH:16]=[CH:15][C:14]=2[Cl:30])=[CH:31][CH:32]=1)(=[O:3])[CH3:1]参加物
4
実験手順
Dissolve 6-{4-(2-methyl-[1,3]dioxolan-2-yl)benzylamino}-7-chloro-3-(2,2,2-trifluoroacetyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine (150 mg, 0.32 mmol) in methanol (5 mL) and add 1N aqueous HCl (1 mL). Stir the solution at ambient temperature for 2 h. Remove the solvent, dissolve the residue in DCM and wash with saturated aqueous NaHCO3. Dry the organic phase over Na2SO4, filter and concentrate. Purify by chromatography on silica gel eluting with hexane/EtOAc (1:0, 9:1, 17:3 and 4:1) to obtain 6-(4-acetyl-benzylamino)-7-chloro-3-(2,2,2-trifluoroacetyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine as an oil (107 mg, 79%). GC-MS m/z/z 424 (M+).
後処理
- customRemove the solvent
- dissolutiondissolve the residue in DCM
- washwash with saturated aqueous NaHCO3
- dry with materialDry the organic phase over Na2SO4
- filtrationfilter
- concentrationconcentrate
- customPurify by chromatography on silica gel eluting with hexane/EtOAc (1:0, 9:1, 17:3 and 4:1)
出典と根拠
- ORDレコード
- ord-e677e2fcda29455cb114b361a732a963
- 出典データセット
- uspto-grants-2011_09
- 特許番号
- US08022062B2
反応ノート
読み込み中…